News Bad Brexit deal threatens plan to hire NHS staff Jeremy Hunt admits a bad Brexit deal could threaten plans to hire more NHS staff.
News Pharma welcomes dialogue with politicians ahead of election Conservative and Labour politicians assure industry with warm words at conference.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
